Obesity-Diabetes Drugs Market

Future Market Insights

Key Insight

The obesity-diabetes drugs market is projected to grow from USD 59.9 billion in 2025 to USD 103.3 billion by 2035, at a CAGR of 5.6%. Drug Therapy will dominate with a 62.7% market share, while oral administration will lead the route of administration segment with a 68.2% share.

October 28, 2025

Anurag Sharma

302 Pages

Cite this Report

Obesity-Diabetes Drugs Market

https://www.futuremarketinsights.com/reports/obesity-diabetes-drugs-market

License

Buy Now

Summary ToC Companies

Key Players

Bayer
Boehringer Ingelheim International GmbH
Glenmark Pharmaceuticals
Janssen Pharmaceuticals Inc
MannKind Corporation
Vertex Pharmaceuticals Incorporated

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Obesity-Diabetes Drugs Market

Key Players

Similar Industry Reports